|Articles|July 1, 2012
- Applied Clinical Trials-07-01-2012
- Volume 21
- Issue 7
Applied Clinical Trials Digital Edition - July 2012
Regulatory: Developing Biosimilars for a Global Market Subject Recruitment: Patient Interest in Clinical Trial Referral CRO/Sponsor: Functional Service Provider Model Also in this issue: Proposed Rule Changes in Europe Global Study Monitors Benchmarks Emergency Department Trials
Advertisement
Articles in this issue
over 13 years ago
Managing Budgets in Complex Times with Tight Variancesover 13 years ago
Act coverover 13 years ago
Business and News Update July 2012over 13 years ago
Increasing Intensity of On-Site Monitoring a Troubling Trendover 13 years ago
Drug Information? Forget it!over 13 years ago
Supply Chain Managementover 13 years ago
Developing Quality Biosimilarsover 13 years ago
Drivers of Patient Interest in Referralover 13 years ago
Risk-Based Monitoring Risky for Sponsors?over 13 years ago
Fresh Doubts Cast Over Post-Marketing TrialsNewsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Imfinzi Regimen Demonstrates 22% Survival Benefit in Early Gastric and GEJ Cancer
2
Thermo Fisher, Lundbeck Announce New OpenAI Partnerships Advancing AI in Drug Development
3
Reducing Site Burden Through Better Technology Integration in Clinical Trials
4
ACT Brief: AI Partnerships, Data-Driven Site Activation, and FDA Approval for Omvoh’s Single-Injection Regimen
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
